450 enterprise customers, 85% repeat revenue, TruBridge adding 2,200 rural hospitals and 15 million patient records, FY30 EBITDA target of Rs 3,000 crore
The US healthcare system is structurally broken in one very specific way — physicians spend a disproportionate amount of their working day on administrative tasks rather than patient care. Documentation, coding, revenue cycle management, prior authorisation and patient scheduling consume hours that should be spent on medicine.
The companies that can take those tasks off the physician’s plate — reliably, accurately, at scale — are building a durable and growing business.
Inventurus Knowledge Solutions is one of them. Founded in 2006 and focused exclusively on the US healthcare workflow outsourcing market, IKS serves 450 large enterprise customers with approximately 85% repeat revenue.
ICICI Direct initiates coverage with a BUY rating and a target price of Rs 2,110 — implying 20% upside from the current market price of Rs 1,752 — based on 32x FY28 EPS.
The Market — $260 Billion
The scale of the addressable opportunity is the starting point of ICICI Direct’s thesis. The US provider workflow market is estimated at approximately USD 260 billion.
Of this, only approximately USD 35 billion is currently outsourced — meaning 87% of the market is still being handled in-house by healthcare providers who are simultaneously dealing with physician shortages, rising regulatory complexity and mounting reimbursement pressure.
“With the outsourced market growing at approximately 12% CAGR, healthcare providers are increasingly outsourcing non-core workflows,” the report states.
At approximately USD 380 million in FY26 revenue, IKS has only approximately 1% share of the outsourced market — “leaving a long runway for share gains,” as the report puts it.
The Acquisitions — TruBridge Changes the Scale
IKS has been building capabilities through two strategic acquisitions that extend far beyond incremental revenue.
Aquity added clinical documentation and coding capabilities and is now largely integrated, “with margins recovering to approximately 33% in Q1FY27,” the report notes — a validation of management’s ability to absorb and improve acquired businesses.
TruBridge is the transformational one. It adds approximately USD 162 billion of rural healthcare market exposure, 2,200 rural hospitals as a customer base, a 700-800 hospital electronic health record footprint and 15 million patient records.
“TruBridge adds approximately USD 162bn rural healthcare market, 2,200+ rural hospitals, a approximately 700-800 hospital EHR footprint and 15mn+ patient records, materially deepening IKS’ access to healthcare workflows and data,” the report states.
The TruBridge acquisition was funded with approximately Rs 5,100-5,200 crore of debt — the balance sheet repair from here is the near-term financial story, and IKS’s operating cash flow exceeding 85% of EBITDA provides the mechanism.
The AI Flywheel
The strategic evolution at IKS is worth understanding carefully. The company is moving from being a service provider that does administrative tasks to being a workflow orchestration platform that uses proprietary data and AI to do those tasks better, faster and with higher accuracy than any competitor can match.
“Combined with its 16+ workflow capabilities and AI products across documentation, coding, RCM and patient access, IKS is moving from doing the work to orchestrating the workflow,” the report states.
The data flywheel that this creates is the durable competitive advantage. More clients generate more workflow data.
More data trains better AI models. Better AI models produce better outcomes. Better outcomes win more clients.
“This creates a potential data flywheel — more clients → more workflow data → better AI models → better outcomes → higher client wins — which, over time, could translate into a durable competitive advantage in healthcare workflows,” ICICI Direct states.
The FY30 Target
Management has set a specific and ambitious FY30 EBITDA target of Rs 3,000 crore — nearly 3x the approximately Rs 1,000 crore TTM EBITDA as of December 2025.
This implies a FY26-30 EBITDA CAGR of approximately 30%. ICICI Direct builds more conservative margin assumptions — 28.3%, 29% and 29.6% for FY27, FY28 and FY29 respectively — but the direction of travel is the same.
“If management executes on integration, margin expansion and debt reduction, earnings growth could outpace revenue growth materially through FY30,” the report states.
Revenue is expected to grow from Rs 3,194 crore in FY26 to Rs 8,842 crore by FY29 — a 40.4% CAGR that is partly organic and partly the full-year contribution of TruBridge. EBITDA grows from Rs 1,091 crore to Rs 2,617 crore. PAT grows from Rs 722 crore to Rs 1,382 crore.
The deleveraging story — operating cash flow above 85% of EBITDA being applied to the approximately Rs 5,100-5,200 crore TruBridge acquisition debt — is what allows PAT to grow at 24.2% CAGR even as revenue grows faster, as interest expenses decline progressively through the forecast period.
Scorecard
| Metric | Value |
|---|---|
| Current Market Price | Rs 1,752 |
| Target Price | Rs 2,110 |
| Upside | 20% |
| Rating | BUY (Initiation) |
| Valuation | 32x FY28E EPS |
| FY28E EPS | Rs 65.8 |
| Revenue CAGR FY26-29E | 40.4% |
| EBITDA CAGR FY26-29E | 33.9% |
| PAT CAGR FY26-29E | 24.2% |
| FY29E EBITDA Margin | 29.6% |
| Total Addressable Market | USD 260 billion |
| Outsourced Market | USD 35 billion |
| IKS Market Share | ~1% |
| Enterprise Customers | 450+ |
| Repeat Revenue | ~85% |
| TruBridge Rural Hospitals | 2,200+ |
The key risks are specifically: longer-than-expected time to reduce net debt to pre-TruBridge levels, and regulatory changes in the US healthcare industry, which accounts for approximately 96% of revenues.
The Wealth Builder Angle
IKS seems to is a business that most Indian investors have not yet fully discovered — a US healthcare workflow outsourcing platform that has built genuine enterprise relationships, is acquiring its way into new market segments, and is now deploying AI on top of a proprietary dataset of clinical and administrative workflows that grows with every client and every transaction.